This website uses cookies. By continuing to use this website you are agreeing to our use of cookies as described in our privacy policy.

Recent Cases May 25, 2018

BCF Plays a Major Role in The Acquisition of a Québec Cannabis Producer by Emerald Health Therapeutics

BCF is proud to have represented Emerald Health Therapeutics (Emerald) in its acquisition of Agro-Biotech, a Québec-based cannabis producer.

This transaction will enable Emerald to produce unique, high-quality cannabis at very low cost and will allow it to be highly responsive to customers in Québec’s province and beyond.

Agro-Biotech is one of only six cannabis licensed producers in Québec. Its assets include 75,000 sq. ft. purpose-built facility whose capacity allows serving high-quality cannabis products in the anticipated legalized adult-use market. This new acquisition further strengthens Emerald’s ability to market throughout eastern Canada and nationwide.

With the anticipated cannabis legalization in Canada, Emerald’s acquisition of Agro-Biotech expands its capacity to meet increased consumers' demands in the second half of 2018.

Emerald has acquired all of the issued and outstanding securities of Agro-Biotech for an aggregate purchase price of $90 million.